Legal-Bay Pre-Settlement Funding Applauds Passage of Kansas Litigation Funding Act
Historic bipartisan legislation advances consumer legal funding access statewide
The historic measure was initiated and championed by
Prior to this legislation, Legal-Bay and other funding providers were unable to operate in
"This is a great day for the industry," said
If you're a lawyer or plaintiff involved in an active lawsuit and need an immediate cash advance against a pending settlement, please visit
Consumer legal funding provides financial relief to plaintiffs involved in ongoing litigation, enabling them to pay for essentials such as rent, groceries, and medical bills without being forced into early or unfair settlements.
Legal-Bay remains committed to responsible funding practices and transparency, ensuring that plaintiffs fully understand the non-recourse nature of their advances. The company continues to advocate for fair regulation that protects consumers while expanding access to funding solutions nationwide.
About Legal-Bay
Legal-Bay is a premier provider of pre-settlement funding services, offering non-recourse cash advances to plaintiffs awaiting settlements in personal injury, employment, and civil litigation cases. With a focus on speed, transparency, and ethical practices, Legal-Bay helps clients maintain financial stability during the legal process.
To apply right now for pre settlement funding, please visit the company's website HERE or call 877.571.0405, where agents are standing by to assist.
Contact: Chris Janish, CEO
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/legal-bay-pre-settlement-funding-applauds-passage-of-kansas-litigation-funding-act-302729361.html
SOURCE Legal-Bay, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L2 Aviation and Gotonomi Extend UAV Connectivity Beyond Cellular Reach
- FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients
- Astellas Doses First Patient in Phase 3 Study of ASP2138 in CLDN18.2-postive and HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share